iScience (May 2022)

Microbiota-mediated skewing of tryptophan catabolism modulates CD4+ T cells in lupus-prone mice

  • Josephine Brown,
  • Georges Abboud,
  • Longhuan Ma,
  • Seung-Chul Choi,
  • Nathalie Kanda,
  • Leilani Zeumer-Spataro,
  • Jean Lee,
  • Weidan Peng,
  • Joy Cagmat,
  • Tamas Faludi,
  • Mansour Mohamadzadeh,
  • Timothy Garrett,
  • Laura Mandik-Nayak,
  • Alexander Chervonsky,
  • Andras Perl,
  • Laurence Morel

Journal volume & issue
Vol. 25, no. 5
p. 104241

Abstract

Read online

Summary: A skewed tryptophan metabolism has been reported in patients with lupus. Here, we investigated the mechanisms by which it occurs in lupus-susceptible mice, and how tryptophan metabolites exacerbate T cell activation. Metabolomic analyses demonstrated that tryptophan is differentially catabolized in lupus mice compared to controls and that the microbiota played a role in this skewing. There was no evidence for differential expression of tryptophan catabolic enzymes in lupus mice, further supporting a major contribution of the microbiota to skewing. However, isolated lupus T cells processed tryptophan differently, suggesting a contribution of T cell intrinsic factors. Functionally, tryptophan and its microbial product tryptamine increased T cell metabolism and mTOR activation, while kynurenine promoted interferon gamma production, all of which have been associated with lupus. These results showed that a combination of microbial and T cell intrinsic factors promotes the production of tryptophan metabolites that enhance inflammatory phenotypes in lupus T cells.

Keywords